HomeComparePYNKF vs MRK

PYNKF vs MRK: Dividend Comparison 2026

PYNKF yields 625.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PYNKF wins by $359450.75M in total portfolio value
10 years
PYNKF
PYNKF
● Live price
625.00%
Share price
$0.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$359450.81M
Annual income
$273,399,800,572.91
Full PYNKF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PYNKF vs MRK

📍 PYNKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPYNKFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PYNKF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PYNKF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PYNKF
Annual income on $10K today (after 15% tax)
$53,125.00/yr
After 10yr DRIP, annual income (after tax)
$232,389,830,486.97/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PYNKF beats the other by $232,389,822,158.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PYNKF + MRK for your $10,000?

PYNKF: 50%MRK: 50%
100% MRK50/50100% PYNKF
Portfolio after 10yr
$179725.43M
Annual income
$136,699,905,185.52/yr
Blended yield
76.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PYNKF
No analyst data
Altman Z
-19.5
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PYNKF buys
0
MRK buys
0
No recent congressional trades found for PYNKF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPYNKFMRK
Forward yield625.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$359450.81M$56.8K
Annual income after 10y$273,399,800,572.91$9,798.13
Total dividends collected$352328.39M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PYNKF vs MRK ($10,000, DRIP)

YearPYNKF PortfolioPYNKF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$73,200$62,500.00$11,206$366.19+$62.0KPYNKF
2$505,894$427,570.09$12,650$502.35+$493.2KPYNKF
3$3,302,979$2,761,671.84$14,407$694.19+$3.29MPYNKF
4$20,385,527$16,851,339.68$16,585$967.82+$20.37MPYNKF
5$119,012,643$97,200,129.44$19,342$1,363.89+$118.99MPYNKF
6$657,683,338$530,339,810.29$22,913$1,947.19+$657.66MPYNKF
7$3,442,734,786$2,739,013,613.82$27,662$2,823.89+$3442.71MPYNKF
8$17,083,489,966$13,399,763,745.21$34,159$4,173.35+$17083.46MPYNKF
9$80,421,501,126$62,142,166,862.30$43,337$6,308.80+$80421.46MPYNKF
10$359,450,806,778$273,399,800,572.91$56,776$9,798.13+$359450.75MPYNKF

PYNKF vs MRK: Complete Analysis 2026

PYNKFStock

Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.

Full PYNKF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PYNKF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PYNKF vs SCHDPYNKF vs JEPIPYNKF vs OPYNKF vs KOPYNKF vs MAINPYNKF vs JNJPYNKF vs ABBVPYNKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.